In the article The who seem to be still relying on tamiflu even with the resistance profile - siting difficulty with absorbtion for patients with gastro/symptoms.and two mechanisms of resistance now all the more reason to fast track production of iv relenza /lani- there has to be a tipping point in next 6 mths when who will be forced to stop whipping this dead dog and it's pup permirivir. I wouldn't be surprised to see a lani deal announcement any day from now till sept. Just because bta mngmt have indicated behond 30 june doesn't mean it will unfold that way,
BTA Price at posting:
$1.25 Sentiment: LT Buy Disclosure: Held
